[Imaging of AIDS in children]

Area of Science:

• Pediatric Infectious Diseases
• Immunology
• HIV/AIDS Research

Background:

• Acquired Immunodeficiency Syndrome (AIDS) in children primarily results from materno-foetal transmission.
• Antiviral therapies and infection prevention strategies have significantly improved the prognosis and survival rates for pediatric AIDS.
• Historically, the prognosis for children with AIDS was poor, but advancements have led to increased longevity.

Purpose of the Study:

• To summarize the current understanding of pediatric AIDS, focusing on transmission, prognosis, clinical manifestations, and survival.
• To differentiate between early-onset severe disease and later-onset disease in children with AIDS.
• To highlight the specific health challenges, including infections and tumors, faced by children living with HIV/AIDS.

Main Methods:

• Review of existing literature and clinical data on pediatric AIDS.
• Analysis of disease progression patterns in children.
• Categorization of clinical manifestations based on affected systems (pulmonary, digestive, central nervous system).

Main Results:

• Two distinct groups of children with AIDS identified: 25% with early, severe disease and 75% with later onset after an asymptomatic period.
• Pulmonary and digestive infections are the most common manifestations in children.
• Central nervous system infections are less common than in adults; neurologic disorders are often directly caused by Human Immunodeficiency Virus (HIV).
• Tumors, including lymphomas and smooth muscle tumors, occur less frequently in children than in adults.

Conclusions:

• Pediatric AIDS management has advanced, improving survival and quality of life.
• Understanding the different disease trajectories is crucial for tailored pediatric HIV care.
• While opportunistic infections remain a concern, direct HIV effects and specific tumor risks characterize pediatric AIDS clinical presentation.